Sands Capital Ventures, LLC 10x Genomics, Inc. Transaction History
Sands Capital Ventures, LLC
- $194 Million
- Q3 2024
A detailed history of Sands Capital Ventures, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 481,770 shares of TXG stock, worth $7.52 Million. This represents 5.61% of its overall portfolio holdings.
Number of Shares
481,770
Previous 481,770
-0.0%
Holding current value
$7.52 Million
Previous $9.37 Million
16.09%
% of portfolio
5.61%
Previous 4.71%
Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$171 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$168 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$101 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$99.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$99.4 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.48B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...